Compare · ADVB vs CI
ADVB vs CI
Side-by-side comparison of Advanced Biomed Inc. (ADVB) and The Cigna Group (CI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ADVB and CI operate in Medical Specialities (Health Care), so they compete in similar markets.
- CI is the larger of the two at $74.25B, about 12610.5x ADVB ($5.9M).
- Over the past year, ADVB is down 77.6% and CI is down 9.7% - CI leads by 67.9 points.
- CI has been more active in the news (9 items in the past 4 weeks vs 2 for ADVB).
- CI has more recent analyst coverage (25 ratings vs 0 for ADVB).
- Company
- Advanced Biomed Inc.
- The Cigna Group
- Price
- $4.30-7.73%
- $280.79+3.66%
- Market cap
- $5.9M
- $74.25B
- 1M return
- -40.85%
- +1.83%
- 1Y return
- -77.56%
- -9.70%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- News (4w)
- 2
- 9
- Recent ratings
- 0
- 25
The Cigna Group
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's U.S. Medical segment offers commercial products and services, including medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as Medicaid plans; and individual health insurance plans to on and off the public exchanges. Its International Markets segment offers health coverage, hospitalization, dental, critical illness, personal accident, term life, medical cost containment, and variable universal life products, as well as health care benefits to mobile employees of multinational organizations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Latest ADVB
- SEC Form DEF 14A filed by Advanced Biomed Inc.
- SEC Form 10-Q filed by Advanced Biomed Inc.
- Advanced Biomed Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits
- Advanced Biomed Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Advanced Biomed Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Advanced Biomed Inc. filed SEC Form 8-K: Leadership Update
- Advanced Biomed Inc. filed SEC Form 8-K: Other Events
- Advanced Biomed Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
- Advanced Biomed Inc. Announces 1 for 20 Share Consolidation
- SEC Form 10-Q filed by Advanced Biomed Inc.
Latest CI
- EVP, Global CIO Koka Durga Prasad covered exercise/tax liability with 729 shares, decreasing direct ownership by 10% to 6,552 units (SEC Form 4) (withholding tax)
- SEC Form 4 filed by Director Kurian George
- The Cigna Group downgraded by Barclays with a new price target
- The Cigna Group downgraded by Deutsche Bank with a new price target
- Chairman & CEO Cordani David exercised 212,543 shares at a strike of $170.34 and sold $59,114,186 worth of shares (201,878 units at $292.82) as part of a pre-agreed trading plan, increasing direct ownership by 23% to 57,766 units (SEC Form 4)
- The Cigna Group filed SEC Form 8-K: Regulation FD Disclosure
- The Cigna Group Announces Appearance at the BofA Securities 2026 Health Care Conference
- Kayne Anderson Energy Infrastructure Fund Announces Appointment of Michael J. Hennigan as New Independent Director
- SEC Form 144 filed by The Cigna Group
- SEC Form 10-Q filed by The Cigna Group